Combined use of intranasal Dexmedetomidine and an oral novel formulation of Midazolam for sedation of young children during brain MRI examination: a prospective, single-center, randomized controlled trial

Table 6 Comparison of sedation onset time, recovery time and overall sedation time between group A and B

Group	n=	Sedation onset time (‾x±SD, min)	Recovery time (‾x±SD, min)	Overall sedation time (‾x±SD, min)
A	77	24.97±16.94	61.88±22.18	86.86±27.26
B	79	27.92±15.83	61.16±28.16	89.09±32.00
t		-1.124	0.177	-0.468
p		0.361	0.692	0.533

Note: All the data were normal distribution, and expressed as the mean ± standard deviation (SD). All enumeration data were expressed as a number. Groups A: 3 ug/kg intranasal DEX plus 0.2 mg/kg oral Midazolam solution (2 mg/ml); Group B: 2 ug/kg intranasal DEX plus 0.2 mg/kg oral Midazolam solution (2 mg/ml)

ISSN: 1471-2253